Previous Page  8 / 9 Next Page
Information
Show Menu
Previous Page 8 / 9 Next Page
Page Background

Volume 4, Issue 6(Suppl)

J Infect Dis Ther

ISSN: 2332-0877 JIDT, an open access journal

Influenza 2016

September 12-13, 2016

Page 36

Notes:

conference

series

.com

Influenza

September 12-13, 2016 Berlin, Germany

2

nd

International Conference on

Ilya B Tsyrlov, J Infect Dis Ther 2016, 4:6(Suppl)

http://dx.doi.org/10.4172/2332-0877.C1.013

Adecade later, another look at what role in global spread of H5N1 played up-regulation by host cell dioxin of gene

encoding type A influenza virus NS1 binding protein

C

ognate DRE sites within DNA enhancer epitomizes wide range of mammalian genes expression mediated via the Ah

receptor pathway. Earlier we postulated the same for DRE-containing viral genes transactivation caused by dioxin in

human cells infected with HIV-1, HBV and HCMV. Here, such mechanistic concept applied to type A influenza virus NS1

binding protein in human and avian (

G. gallus gallus

) host cells. The NS1 is known to prevent transcriptional induction of

antiviral interferons to inhibit splicing and dsRNA-mediated signal transduction in target cells. Presenting data range from

the cellular to population levels. It was shown that gene encoding the NS1 possessed multiple DREs (core nucleotide sequence

3’ A-CGCAC 5’), two of which were identified within the promoter area, namely at positions -7942 and -687. SITECON, an

established computational tool for detecting transcriptional factor binding site recognition, proved the above sites as potentially

active. SITECON-selected adjacent variable sequences were used to detect properties of the DRE site and conformational

similarity score threshold of 0.95 was utilized to rank identified DRE. On the cellular level, Western blot analysis of lysates of

infected or DNA-transfected confluent HeLa cells pretreated with 10 ppt dioxin for 36 hours revealed several-fold increase of

NS1-specific polypeptide. As the NS1 promoter contains two potentially active DRE, an extrapolation from the data on HIV-1

(1 DRE) and HCMV (10 DRE) also suggests that concentration of dioxin up-regulating NS1 gene should be moderately above

current dioxin levels in general population (~4 ppt).Presumably, elevated dioxin level in the host cells might lead to enhanced

ability of NS1 to diminish antiviral interferons. That can bring new insights to the fact that resistance of highly virulent H5N1

to antiviral effects of IFN-β and TNF-alpha directly associated with the NS1. On the population level, the data on wild birds

and domestic poultry (

G. gallus gallus

) dying fromH5N1 in Guangdong province of China and Long An, Tieng Giang and Ben

Tre provinces of Vietnam, all relate to the fact that water and soil in these regions are highly contaminated with dioxin-like

compounds. Eventually, human cohorts from the above regions of China and Vietnam are exposed to elevated concentrations

of dioxin, which might serve as a promotional factor for seasonal influenza outbreaks. Moreover, the sub-nanomolar body

burden dioxin might strongly facilitate spreading of the H5N1 in case avian flu pandemic were to occur.

Biography

Ilya B Tsyrlov has completed his PhD from Novosibirsk University and Postdoctoral studies from Leningrad Academy of Medical Sciences. He is the President and

Chief Scientific Officer of XENOTOX, Inc., an American premier biomedical innovation organization. He has published 4 monographs and about 250 papers in

reputed journals and has been serving as an Editorial Board Member of several journals.

xenotoxit@optonline.net

Ilya B Tsyrlov

XENOTOX Inc., USA